Abstract:Nowadays, non-resolving inflammation is becoming a major trigger in various diseases as it plays a significant role in the pathogenesis of atherosclerosis, asthma, cancer, obesity, inflammatory bowel disease, chronic obstructive pulmonary disease, neurodegenerative disease, multiple sclerosis, and rheumatoid arthritis. However, prolonged use of anti-inflammatory drugs is usually accompanied with undesirable effects and hence more patients tend to seek for natural compounds as alternative medicine. Considering the fact above, there is an urgency to discover and develop potential novel, safe and efficacious natural compounds as drug candidates for future anti-inflammatory therapy. Genistein belongs to the flavonoid family, in the subgroup of isoflavones. It is a phytoestrogen that is mainly derived from legumes. It is a naturally occurring chemical constituent with a similar chemical structure to mammalian estrogens. It is claimed to exert many beneficial effects on health, such as protection against osteoporosis, reduction in the risk of cardiovascular disease, alleviation of postmenopausal symptoms and anticancer properties. In the past, numerous in vitro and in vivo studies have been conducted to investigate the anti-inflammatory potential of genistein. Henceforth, this review aims to summarize the anti-inflammatory properties of genistein linking with the signaling pathways and mediators that are involved in the inflammatory response as well as its toxicity profile. The current outcomes are analysed to highlight the prospect as a lead compound for drug discovery. Data was collected using PubMed, ScienceDirect, SpringerLink and Scopus databases. Results showed that genistein possessed strong anti-inflammatory activities through inhibition of various signaling pathways such as nuclear factor kappa-B (NF- κ B), prostaglandins (PGs), inducible nitric oxide synthase (iNOS), proinflammatory cytokines and reactive oxygen species (ROS). A comprehensive assessment of the mechanism of action in anti-inflammatory effects of genistein is included. However, evidence for the pharmacological effects is still lacking. Further studies using various animal models to assess pharmacological effects such as toxicity, pharmacokinetics, pharmacodynamics, and bioavailability studies are required before clinical studies can be conducted. This review will highlight the potential use of genistein as a lead compound for future drug development as an anti-inflammatory agent.

Robust anti-inflammatory activity of genistein against neutrophil elastase: a microsecond molecular dynamics simulation study

Identification of novel human neutrophil elastase inhibitors from dietary phytochemicals using in silico and in vitro studies

Utilization of computational methods for the identification of new natural inhibitors of human neutrophil elastase in inflammation therapy

Exploration of novel human neutrophil elastase inhibitors from natural compounds: Virtual screening, in vitro, molecular dynamics simulation and in vivo study

Structure-activity relationships of dihydropyrimidone inhibitors against native and auto-processed human neutrophil elastase

Robustaflavone as a novel scaffold for inhibitors of native and auto-proteolysed human neutrophil elastase

Anti-inflammatory potential of selective small compounds by targeting TNF-α & NF-kB signaling: a comprehensive molecular docking and simulation study

Natural Compounds as Inhibitors of Human Neutrophil Elastase

EXPLORING THE PHARMACOLOGICAL MECHANISM OF NARINGENIN AND ITS DERIVATIVES AGAINST RHEUMATOID ARTHRITIS USING NETWORK PHARMACOLOGY AND MOLECULAR DOCKING TECHNIQUES

Identification and characterization of aptameric inhibitors of human neutrophil elastase

Potential Inhibition of Human Neutrophil Elastase Enzyme to Attenuate Emphysema; A Molecular Docking Study

Investigating Polypharmacology Through Targeting Known Human Neutrophil Elastase Inhibitors to Proteinase 3

Terpenoids as Human Neutrophil Elastase (HNE) Inhibitors: a comprehensive review of Natural Anti‐inflammatory Isoprenoids

Deep learning based predictive modeling to screen natural compounds against TNF-alpha for the potential management of Rheumatoid Arthritis: Virtual screening to comprehensive in silico investigation

Genistein Modulate Immune Responses in Collagen-Induced Rheumatoid Arthritis Model.

IN VITRO ANTI-NEUROINFLAMMATORY EFFECT OF GENISTEIN (4',5,7-TRIHYDROXYISOFLAVONE) ON MICROGLIA HMC3 CELL LINE, AND IN SILICO EVALUATION OF ITS INTERACTION WITH ESTROGEN RECEPTOR-β

In-silico screening of phytochemicals from Tridax procumbens. Linn against human neutrophil elastase targeting chronic obstructive pulmonary disease

Exploration of Potential Anti‐inflammatory cum Anti‐Rheumatoid‐arthritis Phyto‐molecule through Integrated Green Approach: Network Pharmacology, Molecular Docking, Molecular dynamics, In‐vitro and Ex‐vivo study

Nanoparticle-inhibited neutrophil elastase prevents neutrophil extracellular trap and alleviates rheumatoid arthritis in C57BL/6 mice

Genistein: A Review on its Anti-Inflammatory Properties

Probing the interactions of genistein with HMGB1 through multi-spectroscopic and in-silico approaches